Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
Pasternak B, Wintzell V, Melbye M, et al.
BMJ 2020;369:m1186
Leggi
Pasternak B, Wintzell V, Melbye M, et al.
BMJ 2020;369:m1186
Leggi
Ellahham S
Am J Med. Pub. online 20 April 2020
Leggi
Ehrmann D, Kulzer B, Roos T, et al.
Lancet Diabet Endocrinol. 2020;8(5):436-46
Leggi
Garg SK, Rodbard D, Hirsch IB, Forlenza GP
Diabetes Technol Ther. Pub. online 17 April 2020
Leggi
Yabe D, Nakamura J, Kaneto H, et al.
Lancet Diabet Endocrinol. 2020;8(5):392-406
Leggi
Ghosh-Swaby OR, Goodman SG, Leiter LA, et al.
Lancet Diabet Endocrinol. 2020;8(5):418-35
Leggi
Ye B, Zhong C, Li Q, et al.
Am J Epidemiol. Pub. online 14 April 2020
Leggi
Yamada Y, Katagiri H, Hamamoto Y, et al.
Lancet Diabet Endocrinol. 2020;8(5):377-91
Leggi
Qiang JK, Sutradhar R, Giannakeas V, et al.
Diabetologia. 2020;63:944-53
Leggi